PENG Block vs Suprainguinal FICB vs Lumbar ESPB for Analgesia After Hip Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65-100
SponsorPoznan University of Medical Sciences

About this trial

This randomized, double-blinded, controlled clinical trial compares three motor-sparing regional anesthesia techniques used for postoperative analgesia in patients undergoing hip arthroplasty: the Pericapsular Nerve Group (PENG) block, the suprainguinal Fascia Iliaca Compartment Block (S-FICB), and the Lumbar Erector Spinae Plane Block (L-ESPB). Although all three techniques are widely used in modern hip surgery, their relative analgesic efficacy, opioid-sparing potential, and impact on early functional recovery have not been directly compared in a single study.

The primary objective is to determine which block provides the most effective postoperative analgesia while preserving motor function and facilitating early mobilization. Secondary objectives include comparisons of opioid consumption, pain scores at rest and during movement, time to first rescue analgesia, block-related adverse events, quadriceps strength, incidence of postoperative nausea and vomiting, and early functional outcomes.

This study aims to identify the optimal motor-sparing regional anesthesia strategy for older adults undergoing hip arthroplasty.

Eligibility criteria

Qualifiers

Adults aged 65 years or older scheduled to undergo elective hip arthroplasty under spinal anesthesia.

Ability to provide written informed consent.

Ability to understand and reliably use numerical pain assessment tools (NRS 0-10).

ASA physical status II-III.

Disqualifiers

Inability to provide informed consent due to cognitive impairment, language barrier, or severe hearing/speech limitations.

Coagulopathy or therapeutic anticoagulation not meeting safety criteria for regional anesthesia.

Local infection at the planned block site.

Allergy, hypersensitivity, or contraindication to ropivacaine, local anesthetics, or study medications.

Trial design

Treatments tested in this trial

  • Pericapsular Nerve Group (PENG) Block
  • Suprainguinal Fascia Iliaca Compartment Block (S-FICB)
  • Lumbar Erector Spinae Plane Block (L-ESPB)

Treatment groups

93 Participants
are divided into 3 treatment groups